Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06843603 · ClinicalTrials.gov registry record · NA
Barriers/Facilitators and Care Coordination of Native Hawaiians & Kidney Disease
A NA study, sponsored by University of Hawaii.
- Not yet
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT06843603: Clinical Trial NA study, sponsored by University of Hawaii.
NCT06843603 is a NA study that has not yet begun recruiting, run by University of Hawaii. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06843603, a NA study, has not yet begun recruiting, sponsored by University of Hawaii.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
Native Hawaiians (NH) are 9.5 times more likely to be on dialysis or need a kidney transplant compared to Whites. They have the highest end-stage kidney disease (ESKD) incidence rates in the nation, begin dialysis at younger ages (30-50 years), and one of the most under-studied racial/ethnic groups in chronic kidney disease (CKD) research. This project's outcome is to improve kidney disease follow-up among early stage NHs at high risk by aligning health equity with a culturally appropriate care coordination systems model.
Primary Outcome
Acceptability (the degree to which an intervention is perceived a good fit) Acceptability will be measured by a survey likert scale of 1 (not acceptable) - 10 (most acceptable) Name of measurement tool is reference in Procter et al (p. 69): Procter E, Silmere H, Raghavan R, et al. Outcomes for implementation research, conceptual distinctions, measurement challenges, and research agenda. Adm Policy Mental Health. 2022: 38 (2): 65-76.
Interventions
- BEHAVIORAL culturally informed care coordination intervention
- OTHER No Intervention - Usual Care Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What is known before NCT06843603 opens enrollment
NCT06843603 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which culturally informed care coordination intervention is the first listed.
NCT06843603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06843603 about?
NCT06843603 is a clinical study titled "Barriers/Facilitators and Care Coordination of Native Hawaiians & Kidney Disease". Native Hawaiians (NH) are 9.5 times more likely to be on dialysis or need a kidney transplant compared to Whites. They have the highest end-stage kidney disease (ESKD) incidence rates in the nation, begin dialysis at younger ages (30-50 years), and one of the most under-studied racial/ethnic groups ...
What is the current status of trial NCT06843603?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-09-01. Estimated completion is 2027-08-31.
What interventions are being tested in trial NCT06843603?
The interventions under investigation include: culturally informed care coordination intervention (BEHAVIORAL), No Intervention - Usual Care Group (OTHER).
Who is sponsoring clinical trial NCT06843603?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06843603's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI